Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Finished Goods (2019 - 2020)

Sunshine Biopharma (SBFM) has disclosed Finished Goods for 2 consecutive years, with $23771.0 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Finished Goods rose 49.41% year-over-year to $23771.0, compared with a TTM value of $23771.0 through Dec 2020, up 49.41%, and an annual FY2020 reading of $23771.0, up 49.41% over the prior year.
  • Finished Goods was $23771.0 for Q4 2020 at Sunshine Biopharma, up from $15910.0 in the prior quarter.
  • Across five years, Finished Goods topped out at $23771.0 in Q4 2020 and bottomed at $15910.0 in Q4 2019.